The Fusion Pharmaceuticals brand, founded in 2014 (Canada), from 585 sister brands and 17478 competing brands. The Fusion Pharmaceuticals brand is owned by ASTRAZENECA, a company listed in London. Its International Securities Identification Number (ISIN) is GB0009895292. The sector of Fusion Pharmaceuticals is Drug Manufacturers.

Fusion Pharmaceuticals is a brand of ASTRAZENECA (AZN/L) Share price

Share price and profitability of the share ASTRAZENECA (Fusion Pharmaceuticals)

Buy ASTRAZENECA share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit

Investment simulator :

Amount invested GBX 12,554.00

Portfolio valuation
ASTRAZENECA (Fusion Pharmaceuticals) over 5 years* GBX 25,905.55

Stock market history ASTRAZENECA (Fusion Pharmaceuticals)

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more